PEAR Therapeutics to Participate in BIO CEO & Investor Conference and LEERINK Partners 7th Annual Global Healthcare Conference

BOSTON, and SAN FRANCISCO, February 6, 2018—PEAR Therapeutics, the leader in prescription digital therapeutics, today announced that Corey McCann, M.D., Ph.D., President and CEO of PEAR Therapeutics, will present a company update at the annual BIO CEO & Investor Conference taking place on Tuesday, February 13, 2018, at the New York Marriott Marquis in New York. The company also will participate in the LEERINK Partners 7th Annual Global Healthcare Conference taking place February 14-15, 2018, at the Lotte New York Palace Hotel in New York.

Click here for the full PEAR Press Release…